180 Life Sciences Corp (ATNF)

1.68 -0.06 (-3.45%) USD  |  NASDAQ  |  May 23, 14:04
More

180 Life Sciences Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for ATNF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2021. Upgrade now.
Date Value
August 10, 2022 --
May 09, 2022 --
March 31, 2022 --
Date Value
February 02, 2022 --
December 31, 2021 --
September 15, 2021 --

Revenue Estimates for Current Quarter Range, Past 5 Years

--
Minimum
Sep 15 2021
--
Maximum
Sep 15 2021
--
Average
--
Median
Sep 15 2021

Revenue Estimates for Current Quarter Benchmarks

Altimmune Inc Upgrade
Seelos Therapeutics Inc Upgrade
GT Biopharma Inc Upgrade
Outlook Therapeutics Inc Upgrade
MAIA Biotechnology Inc Upgrade

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade